Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | GPCR, family 2 | 0.0012 | 0.0027 | 0.0027 |
Schistosoma mansoni | hypothetical protein | 0.0128 | 0.1949 | 0.2297 |
Mycobacterium tuberculosis | Probable cytochrome P450 124 Cyp124 | 0.0023 | 0.0207 | 0.4841 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.0027 | 0.0075 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0053 | 0.0703 | 0.1932 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0522 | 0.8484 | 1 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0103 | 0.1531 | 0.2298 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0015 | 0.0073 | 0.1704 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD7 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0026 | 0.025 | 0.5844 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0428 | 0.1176 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0012 | 0.0027 | 0.0075 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0103 | 0.1531 | 0.2298 |
Mycobacterium tuberculosis | Probable cytochrome P450 130 Cyp130 | 0.0023 | 0.0207 | 0.4841 |
Brugia malayi | MH2 domain containing protein | 0.0093 | 0.1373 | 0.3775 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0012 | 0.002 | 0.0887 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0412 | 0.666 | 1 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0012 | 0.002 | 0.0887 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0012 | 0.002 | 0.0746 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0035 | 0.0396 | 0.0396 |
Mycobacterium ulcerans | cytochrome P450 144A4 Cyp144A4 | 0.0023 | 0.0207 | 0.4841 |
Brugia malayi | Cytochrome P450 family protein | 0.003 | 0.0321 | 0.0882 |
Echinococcus granulosus | dna polymerase eta | 0.0035 | 0.0404 | 0.0476 |
Chlamydia trachomatis | acylglycerophosphoethanolamine acyltransferase | 0.0027 | 0.0275 | 0.5 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0025 | 0.0231 | 0.5719 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0035 | 0.0396 | 0.0396 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0015 | 0.0073 | 0.1805 |
Mycobacterium tuberculosis | Cytochrome P450 121 Cyp121 | 0.0023 | 0.0207 | 0.4841 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0015 | 0.0073 | 0.1805 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0015 | 0.0073 | 0.1805 |
Mycobacterium ulcerans | cytochrome P450 124A1, Cyp124A1 | 0.0023 | 0.0207 | 0.4841 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0012 | 0.002 | 0.0024 |
Echinococcus granulosus | geminin | 0.0128 | 0.1949 | 0.2297 |
Echinococcus granulosus | GPCR family 2 | 0.0012 | 0.0027 | 0.0032 |
Entamoeba histolytica | modulator of drug activity B homolog, putative | 0.0103 | 0.1531 | 1 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0012 | 0.002 | 0.002 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0428 | 0.1176 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0275 | 0.0755 |
Mycobacterium ulcerans | cytochrome P450 125A7 Cyp125A7 | 0.0023 | 0.0207 | 0.4841 |
Mycobacterium tuberculosis | Possible cytochrome P450 126 Cyp126 | 0.0023 | 0.0207 | 0.4841 |
Mycobacterium ulcerans | cytochrome P450 143A3 Cyp143A3 | 0.0023 | 0.0207 | 0.4841 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0023 | 0.0207 | 0.4841 |
Mycobacterium tuberculosis | Probable cytochrome P450 128 Cyp128 | 0.0023 | 0.0207 | 0.4841 |
Trypanosoma brucei | cytochrome P450, putative | 0.003 | 0.0321 | 0.7946 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0103 | 0.1531 | 0.2298 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0103 | 0.1531 | 0.2298 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0015 | 0.0073 | 0.1805 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0103 | 0.1531 | 0.2298 |
Mycobacterium tuberculosis | Probable cytochrome P450 139 Cyp139 | 0.0023 | 0.0207 | 0.4841 |
Brugia malayi | AMP-binding enzyme family protein | 0.0036 | 0.0428 | 0.1176 |
Mycobacterium tuberculosis | Probable cytochrome P450 132 Cyp132 | 0.0023 | 0.0207 | 0.4841 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0027 | 0.0275 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 138 Cyp138 | 0.0023 | 0.0207 | 0.4841 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0015 | 0.0073 | 0.1805 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0275 | 0.0755 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0103 | 0.1531 | 0.2298 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0522 | 0.8484 | 0.8484 |
Mycobacterium tuberculosis | Cytochrome P450 51 Cyp51 (CYPL1) (P450-L1A1) (sterol 14-alpha demethylase) (lanosterol 14-alpha demethylase) (P450-14DM) | 0.0023 | 0.0207 | 0.4841 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0103 | 0.1531 | 0.2298 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0015 | 0.0073 | 0.1805 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0036 | 0.0428 | 1 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0012 | 0.002 | 0.002 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0412 | 0.666 | 1 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0103 | 0.1531 | 0.2298 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0103 | 0.1531 | 0.2298 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0012 | 0.0027 | 0.0027 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.003 | 0.0321 | 0.0882 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0012 | 0.002 | 0.0507 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0412 | 0.666 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0015 | 0.0073 | 0.1805 |
Echinococcus multilocularis | geminin | 0.0128 | 0.1949 | 0.1949 |
Schistosoma mansoni | hypothetical protein | 0.0012 | 0.0027 | 0.0032 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0015 | 0.0073 | 0.1704 |
Trypanosoma brucei | unspecified product | 0.0015 | 0.0073 | 0.1805 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0103 | 0.1531 | 0.2298 |
Onchocerca volvulus | Huntingtin homolog | 0.0093 | 0.136 | 1 |
Mycobacterium tuberculosis | Possible cytochrome P450 135B1 Cyp135B1 | 0.0023 | 0.0207 | 0.4841 |
Loa Loa (eye worm) | cytochrome P450 | 0.0023 | 0.0207 | 0.0569 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0039 | 0.047 | 0.1292 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0036 | 0.0428 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0275 | 0.0755 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0036 | 0.0428 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0036 | 0.0428 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0035 | 0.0396 | 0.0467 |
Brugia malayi | Cytochrome P450 family protein | 0.003 | 0.0321 | 0.0882 |
Schistosoma mansoni | hypothetical protein | 0.0027 | 0.0265 | 0.0312 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0015 | 0.0073 | 0.0109 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0015 | 0.0073 | 0.1805 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0036 | 0.0428 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0015 | 0.0073 | 0.1805 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0012 | 0.002 | 0.0479 |
Schistosoma mansoni | DNA polymerase eta | 0.0035 | 0.0404 | 0.0476 |
Mycobacterium ulcerans | cytochrome P450 136A2 Cyp136A2 | 0.0023 | 0.0207 | 0.4841 |
Mycobacterium ulcerans | cytochrome P450 191A3 Cyp191A3 | 0.0023 | 0.0207 | 0.4841 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0428 | 0.1176 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0027 | 0.0265 | 0.0728 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0103 | 0.1531 | 0.2298 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0015 | 0.0073 | 0.1805 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0103 | 0.1531 | 0.2298 |
Echinococcus multilocularis | muscleblind protein | 0.023 | 0.3638 | 0.3638 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD5 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0026 | 0.025 | 0.5844 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0039 | 0.047 | 0.1292 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0093 | 0.1373 | 0.3775 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0103 | 0.1531 | 0.2298 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0012 | 0.002 | 0.0024 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0015 | 0.0073 | 0.1805 |
Mycobacterium ulcerans | cytochrome P450 140A5 Cyp140A5 | 0.0023 | 0.0207 | 0.4841 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0012 | 0.0027 | 0.0075 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD35 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0026 | 0.025 | 0.5844 |
Mycobacterium ulcerans | cytochrome P450 188A3 Cyp188A3 | 0.0023 | 0.0207 | 0.4841 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0275 | 0.0755 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0012 | 0.002 | 0.0056 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0012 | 0.0027 | 0.0032 |
Trypanosoma cruzi | cytochrome P450, putative | 0.003 | 0.0321 | 0.7946 |
Brugia malayi | AMP-binding enzyme family protein | 0.0036 | 0.0428 | 0.1176 |
Mycobacterium ulcerans | cytochrome P450 150A6 Cyp150A6 | 0.0023 | 0.0207 | 0.4841 |
Mycobacterium leprae | putative cytochrome p450 | 0.0023 | 0.0207 | 0.4841 |
Mycobacterium tuberculosis | Probable cytochrome P450 140 Cyp140 | 0.0023 | 0.0207 | 0.4841 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0015 | 0.0073 | 0.1704 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD3 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0026 | 0.025 | 0.5844 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0103 | 0.1531 | 0.2298 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0015 | 0.0073 | 0.1704 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0035 | 0.0396 | 0.1089 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0103 | 0.1531 | 0.2298 |
Mycobacterium ulcerans | cytochrome P450 142A3 Cyp142A3 | 0.0023 | 0.0207 | 0.4841 |
Trypanosoma cruzi | cytochrome P450, putative | 0.003 | 0.0321 | 0.7946 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0035 | 0.0396 | 0.0467 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0412 | 0.666 | 1 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0103 | 0.1531 | 0.2298 |
Echinococcus multilocularis | neuropeptide s receptor | 0.0349 | 0.5626 | 0.5626 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.003 | 0.0321 | 0.7502 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0035 | 0.0396 | 0.0467 |
Mycobacterium ulcerans | cytochrome P450 189A7 Cyp189A7 | 0.0023 | 0.0207 | 0.4841 |
Entamoeba histolytica | hypothetical protein | 0.0103 | 0.1531 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 144 Cyp144 | 0.0023 | 0.0207 | 0.4841 |
Leishmania major | lanosterol 14-alpha-demethylase, putative | 0.0023 | 0.0207 | 0.4841 |
Entamoeba histolytica | iron-sulfur flavoprotein, putative | 0.0103 | 0.1531 | 1 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0103 | 0.1531 | 0.2298 |
Trypanosoma cruzi | Lanosterol 14-alpha demethylase | 0.0023 | 0.0207 | 0.5128 |
Leishmania major | DNA polymerase eta, putative | 0.0025 | 0.0231 | 0.5399 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0035 | 0.0404 | 1 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0103 | 0.1531 | 0.2298 |
Mycobacterium ulcerans | cytochrome P450 123A3 Cyp123A3 | 0.0023 | 0.0207 | 0.4841 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0103 | 0.1531 | 0.2298 |
Leishmania major | DNA polymerase kappa, putative | 0.0015 | 0.0073 | 0.1704 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0012 | 0.002 | 0.0746 |
Trypanosoma brucei | Lanosterol 14-alpha demethylase | 0.0023 | 0.0207 | 0.5128 |
Loa Loa (eye worm) | CYP4Cod1 | 0.003 | 0.0321 | 0.0882 |
Mycobacterium tuberculosis | Probable cytochrome P450 137 Cyp137 | 0.0023 | 0.0207 | 0.4841 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0412 | 0.666 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0039 | 0.047 | 0.1292 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0015 | 0.0073 | 0.1805 |
Loa Loa (eye worm) | hypothetical protein | 0.023 | 0.3638 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0103 | 0.1531 | 0.2298 |
Mycobacterium ulcerans | cytochrome P450 187A4 Cyp187A4 | 0.0023 | 0.0207 | 0.4841 |
Leishmania major | DNA polymerase eta, putative | 0.0035 | 0.0404 | 0.9441 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0012 | 0.0027 | 0.0032 |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0012 | 0.002 | 0.0479 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0309 | 0.4951 | 0.7435 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0103 | 0.1531 | 0.2298 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0103 | 0.1531 | 0.2298 |
Entamoeba histolytica | acyl-coA synthetase, putative | 0.0036 | 0.0428 | 0.2795 |
Echinococcus granulosus | neuropeptide receptor A26 | 0.0349 | 0.5626 | 0.6632 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0012 | 0.002 | 0.0507 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.0025 | 0.0231 | 1 |
Onchocerca volvulus | Huntingtin homolog | 0.0093 | 0.136 | 1 |
Echinococcus multilocularis | dna polymerase kappa | 0.0015 | 0.0073 | 0.0073 |
Mycobacterium tuberculosis | Probable cytochrome P450 123 Cyp123 | 0.0023 | 0.0207 | 0.4841 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0012 | 0.0027 | 0.0075 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0015 | 0.0073 | 0.02 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0412 | 0.666 | 1 |
Brugia malayi | Muscleblind-like protein | 0.023 | 0.3638 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0023 | 0.0207 | 0.0244 |
Brugia malayi | AMP-binding enzyme family protein | 0.0036 | 0.0428 | 0.1176 |
Mycobacterium tuberculosis | Probable cytochrome P450 143 Cyp143 | 0.0023 | 0.0207 | 0.4841 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0412 | 0.666 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0015 | 0.0073 | 0.1805 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0103 | 0.1531 | 0.2298 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0412 | 0.666 | 1 |
Echinococcus granulosus | muscleblind protein | 0.023 | 0.3638 | 0.4288 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0027 | 0.0275 | 1 |
Trypanosoma cruzi | cytochrome p450-like protein, putative | 0.0023 | 0.0207 | 0.5128 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0012 | 0.002 | 0.002 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0015 | 0.0073 | 0.0073 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0015 | 0.0073 | 0.1704 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0103 | 0.1531 | 0.2298 |
Echinococcus multilocularis | muscleblind protein 1 | 0.023 | 0.3638 | 0.3638 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0412 | 0.666 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0093 | 0.1373 | 0.3775 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0412 | 0.666 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0015 | 0.0073 | 0.1805 |
Mycobacterium ulcerans | cytochrome P450 187A5 Cyp187A5 | 0.0023 | 0.0207 | 0.4841 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.047 | 0.1292 |
Brugia malayi | hypothetical protein | 0.0093 | 0.136 | 0.3738 |
Loa Loa (eye worm) | hypothetical protein | 0.0093 | 0.136 | 0.3738 |
Echinococcus granulosus | microtubule associated protein 2 | 0.0522 | 0.8484 | 1 |
Onchocerca volvulus | 0.0036 | 0.0428 | 0.3146 | |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0036 | 0.0428 | 0.2795 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0036 | 0.0428 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0012 | 0.0027 | 0.0032 |
Mycobacterium ulcerans | cytochrome P450 143A4 Cyp143A4 | 0.0023 | 0.0207 | 0.4841 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0275 | 0.0755 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0012 | 0.002 | 0.0507 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0036 | 0.0428 | 1 |
Mycobacterium ulcerans | cytochrome P450 108B4 Cyp108B4 | 0.0023 | 0.0207 | 0.4841 |
Schistosoma mansoni | hypothetical protein | 0.0012 | 0.0027 | 0.0032 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0036 | 0.0428 | 1 |
Echinococcus multilocularis | dna polymerase eta | 0.0035 | 0.0404 | 0.0404 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0412 | 0.666 | 1 |
Mycobacterium ulcerans | cytochrome P450 51B1 Cyp51B1 | 0.0023 | 0.0207 | 0.4841 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0035 | 0.0396 | 0.0467 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0265 | 0.0728 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0412 | 0.666 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0012 | 0.0027 | 0.0032 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0103 | 0.1531 | 0.2298 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0412 | 0.666 | 1 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0012 | 0.002 | 0.002 |
Leishmania major | cytochrome p450-like protein | 0.003 | 0.0321 | 0.7502 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0027 | 0.0275 | 0.6421 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0015 | 0.0073 | 0.1805 |
Trypanosoma cruzi | Lanosterol 14-alpha demethylase | 0.0023 | 0.0207 | 0.5128 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0103 | 0.1531 | 0.2298 |
Leishmania major | cytochrome p450-like protein | 0.0023 | 0.0207 | 0.4841 |
Schistosoma mansoni | cytochrome P450 | 0.0023 | 0.0207 | 0.0244 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0412 | 0.666 | 1 |
Leishmania major | cytochrome p450-like protein | 0.0023 | 0.0207 | 0.4841 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0036 | 0.0428 | 1 |
Echinococcus multilocularis | neuropeptide receptor A26 | 0.0349 | 0.5626 | 0.5626 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0036 | 0.0428 | 1 |
Trichomonas vaginalis | FMN-dependent NADH-azoreductase, putative | 0.0103 | 0.1531 | 0.2298 |
Loa Loa (eye worm) | hypothetical protein | 0.023 | 0.3638 | 1 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0012 | 0.002 | 0.0507 |
Mycobacterium tuberculosis | Probable cytochrome P450 monooxygenase 142 Cyp142 | 0.0023 | 0.0207 | 0.4841 |
Mycobacterium tuberculosis | Probable cytochrome P450 141 Cyp141 | 0.0023 | 0.0207 | 0.4841 |
Toxoplasma gondii | cytochrome p450 superfamily protein | 0.0023 | 0.0207 | 0.8967 |
Brugia malayi | cytochrome P450 | 0.0023 | 0.0207 | 0.0569 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0035 | 0.0404 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0412 | 0.666 | 1 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0036 | 0.0428 | 0.2795 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0035 | 0.0396 | 0.1089 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0036 | 0.0428 | 1 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.0027 | 0.0275 | 0.6421 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0036 | 0.0428 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0015 | 0.0073 | 0.1805 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0036 | 0.0428 | 1 |
Echinococcus granulosus | cytochrome P450 2K1 | 0.0023 | 0.0207 | 0.0244 |
Mycobacterium ulcerans | cytochrome P450 105Q4 Cyp105Q4 | 0.0023 | 0.0207 | 0.4841 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0036 | 0.0428 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0103 | 0.1531 | 0.2298 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0103 | 0.1531 | 0.2298 |
Mycobacterium tuberculosis | Possible cytochrome P450 135A1 Cyp135A1 | 0.0023 | 0.0207 | 0.4841 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0035 | 0.0396 | 0.0467 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0412 | 0.666 | 1 |
Brugia malayi | isocitrate dehydrogenase | 0.0012 | 0.002 | 0.0056 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0035 | 0.0404 | 0.111 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0404 | 0.111 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0412 | 0.666 | 1 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0103 | 0.1531 | 0.2298 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0015 | 0.0073 | 0.0086 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0412 | 0.666 | 1 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0012 | 0.002 | 0.002 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0015 | 0.0073 | 0.1805 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0412 | 0.666 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0093 | 0.136 | 0.3738 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.003 | 0.0321 | 0.0882 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0012 | 0.0027 | 0.0027 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0036 | 0.0428 | 1 |
Mycobacterium tuberculosis | Probable cytochrome P450 136 Cyp136 | 0.0023 | 0.0207 | 0.4841 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0103 | 0.1531 | 0.2298 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0015 | 0.0073 | 0.0476 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0015 | 0.0073 | 0.02 |
Mycobacterium tuberculosis | Probable cytochrome P450 125 Cyp125 | 0.0023 | 0.0207 | 0.4841 |
Schistosoma mansoni | hypothetical protein | 0.0128 | 0.1949 | 0.2297 |
Echinococcus granulosus | dna polymerase kappa | 0.0015 | 0.0073 | 0.0086 |
Mycobacterium ulcerans | cytochrome p450 150 cyp150 | 0.0023 | 0.0207 | 0.4841 |
Echinococcus multilocularis | 0.0023 | 0.0207 | 0.0207 | |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0103 | 0.1531 | 0.2298 |
Mycobacterium ulcerans | cytochrome P450 126A3 Cyp126A3 | 0.0023 | 0.0207 | 0.4841 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0015 | 0.0073 | 0.0086 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0015 | 0.0073 | 0.0109 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0015 | 0.0073 | 0.0086 |
Echinococcus granulosus | neuropeptide s receptor | 0.0349 | 0.5626 | 0.6632 |
Brugia malayi | Cytochrome P450 family protein | 0.0053 | 0.0703 | 0.1932 |
Brugia malayi | Isocitrate dehydrogenase | 0.0012 | 0.002 | 0.0056 |
Brugia malayi | Cytochrome P450 family protein | 0.0023 | 0.0207 | 0.0569 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.